---
title: "Anhui Fengyuan Pharmaceutical Co.,Ltd. (000153.SZ)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/000153.SZ.md"
symbol: "000153.SZ"
name: "Anhui Fengyuan Pharmaceutical Co.,Ltd."
industry: "Pharmaceuticals"
datetime: "2026-05-20T18:34:39.408Z"
locales:
  - [en](https://longbridge.com/en/quote/000153.SZ.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/000153.SZ.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/000153.SZ.md)
---

# Anhui Fengyuan Pharmaceutical Co.,Ltd. (000153.SZ)

## Company Overview

Anhui Fengyuan Pharmaceutical Co., Ltd. researches and develops, produces, and sells medicines in China. The company also exports its products. Anhui Fengyuan Pharmaceutical Co., Ltd.

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Exchange | CN Market |
| Website | [www.bbcayy.com](https://www.bbcayy.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:09.000Z

**Overall: C (0.54)**

**Industry**: Pharmaceuticals

| Metric | Value |
|--------|-------|
| Industry Ranking | 162 / 215 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -8.56% |  |
| Net Profit YoY | -35.20% |  |
| P/B Ratio | 1.32 |  |
| Dividend Ratio | 1.62% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 2881519655.73 |  |
| Revenue | 3760053650.25 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 4.63% | C |
| Profit Margin | 2.62% | C |
| Gross Margin | 22.90% | D |
| Revenue YoY | -8.56% | D |
| Net Profit YoY | -35.20% | D |
| Total Assets YoY | 12.03% | B |
| Net Assets YoY | 5.47% | C |
| Cash Flow Margin | 118.15% | C |
| OCF YoY | -8.56% | D |
| Turnover | 0.74 | B |
| Gearing Ratio | 58.98% | D |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Anhui Fengyuan Pharmaceutical Co.,Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-8.56%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-35.20%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "1.32",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "1.62%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "2881519655.73",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "3760053650.25",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "4.63%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "2.62%",
          "rating": "C"
        },
        {
          "name": "Gross Margin",
          "value": "22.90%",
          "rating": "D"
        },
        {
          "name": "Revenue YoY",
          "value": "-8.56%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "-35.20%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "12.03%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "5.47%",
          "rating": "C"
        },
        {
          "name": "Cash Flow Margin",
          "value": "118.15%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "-8.56%",
          "rating": "D"
        },
        {
          "name": "Turnover",
          "value": "0.74",
          "rating": "B"
        },
        {
          "name": "Gearing Ratio",
          "value": "58.98%",
          "rating": "D"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 28.76 | 70/215 | 27.40 | 26.09 | 21.64 |
| PB | 1.30 | 27/215 | 1.51 | 1.46 | 1.40 |
| PS (TTM) | 0.75 | 4/215 | 0.78 | 0.75 | 0.72 |
| Dividend Yield | 1.64% | 83/215 | 1.57% | 1.52% | 1.47% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Allist (688578.SH) | A | A | B | A | B | A |
| 02 | Xingqi Pharmaceutical (300573.SZ) | A | A | A | A | B | A |
| 03 | Hengrui Pharma (600276.SH) | A | B | C | A | B | B |
| 04 | Yunnan Baiyao (000538.SZ) | B | C | B | B | C | B |
| 05 | Haisco (002653.SZ) | A | A | B | B | B | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/000153.SZ/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/000153.SZ/norm.md)
- [Related News](https://longbridge.com/en/quote/000153.SZ/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/000153.SZ/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**